insights_auto
Why is SBS up 8.78%?
Dive Deeperchevron_right
SBS:FRA
Stratec SE
€22.30
arrow_upward
+8.78%(+1.80) 1D
Oct 7, 2:02:45 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SBS...
Open
€21.75
High
€22.30
Low
€21.75
Mkt. cap
268.96M
Avg. vol.
49.00
Volume
60.00
Dividend
2.69%
Quarterly dividend
€0.15
Ex-dividend date
Jun 24, 2026
52-wk high
€32.20
52-wk low
€16.38
EPS
-€0.03
Shares outstanding
11.96M
No. of employees
1K
Open
€21.75
High
€22.30
Low
€21.75
Mkt. cap
268.96M
Avg. vol.
49.00
Volume
60.00
Dividend
2.69%
Quarterly dividend
€0.15
Ex-dividend date
Jun 24, 2026
52-wk high
€32.20
52-wk low
€16.38
EPS
-€0.03
Shares outstanding
11.96M
No. of employees
1K
News stories
From web sources and news partners
AD HOC NEWS
·
1 day ago
mwb research downgrades Stratec stock from Hold to Sell
AD HOC NEWS
·
2 days ago
mwb research downgrades Stratec stock to Sell
AD HOC NEWS
·
2 days ago
Stratec stock pre-market at EUR 21.75: plus 0.09 percent
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics.
As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE